Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.99M Buy
45,908
+1,116
+2% +$186K 0.01% 497
2026
Q1
$9.4M Buy
44,792
+963
+2% +$242K 0.02% 444
2025
Q4
$12.5M Buy
43,829
+9,074
+26% +$2.84M 0.03% 400
2025
Q3
$10.7M Sell
34,755
-38,726
-53% -$12.1M 0.03% 420
2025
Q2
$23.1M Buy
73,481
+7,313
+11% +$2.11M 0.06% 264
2025
Q1
$17.4M Buy
66,168
+35,214
+114% +$9.53M 0.05% 297
2024
Q4
$8.08M Buy
30,954
+2,400
+8% +$604K 0.02% 448
2024
Q3
$6.65M Sell
28,554
-100
-0.3% -$20.5K 0.02% 503
2024
Q2
$5.78M Sell
28,654
-10,105
-26% -$1.82M 0.02% 502
2024
Q1
$6.64M Buy
+38,759
New +$7.23M 0.02% 522

Other funds holding PODD

Danske Bank's PODD Position: Q2 2026 in Review

Danske Bank increased its Insulet (PODD) stake by 2.5% in Q2 2026, buying an estimated $186K and bringing the position to 45,908 shares worth $6.99M. The position accounts for 0.01% of the portfolio, ranked #497.

Danske Bank first reported a position in PODD in Q1 2024 and has held it in 10 quarters since. The position peaked at $23.1M in Q2 2025. 592 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Danske Bank held 45,908 shares of Insulet worth $6.99M as of Q2 2026.
  • Danske Bank bought 1,116 Insulet shares in Q2 2026, an estimated $186K.
  • Insulet made up 0.01% of Danske Bank's portfolio in Q2 2026, its #497 holding.
  • Danske Bank first reported a position in Insulet in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Insulet position peaked at $23.1M in Q2 2025.
  • 592 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.